Naprokseen (Estonian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Naprokseen" in Estonian language version.

refsWebsite

Global rank Estonian rank

17nih.gov

4^th place

14^th place

11doi.org

2^nd place

16^th place

2archive.org

6^th place

41^st place

1bmj.com

1,226^th place

1,336^th place

1aafp.org

1,916^th place

4,197^th place

1web.archive.org

1^st place

1vimovo.com

low place

aafp.org

French L (2005). "Dysmenorrhea" (PDF). Am Fam Physician. 71 (2): 285–91. PMID 15686299.

archive.org

Joint Formulary Committee (2013). British National Formulary (BNF) (65 ed.). London, UK: Pharmaceutical Press. ISBN 978-0-85711-084-8.
Van Hecken A, Schwartz JI, Depré M, De Lepeleire I, Dallob A, Tanaka W, Wynants K, Buntinx A, Arnout J, Wong PH, Ebel DL, Gertz BJ, De Schepper PJ (2000). "Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers". J Clin Pharmacol. 40 (10): 1109–20. DOI:10.1177/009127000004001005. PMID 11028250.

bmj.com

ard.bmj.com

Richy, F; Bruyere, O; Ethgen, O; Rabenda, V; Bouvenot, G; Audran, M; Herrero-Beaumont, G; Moore, A; Eliakim, R; Haim, M; Reginster, JY (2004). "Time dependent risk of gastrointestinal complications induced by nonsteroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach". Annals of the Rheumatic Diseases. 63 (7): 759–66. DOI:10.1136/ard.2003.015925. PMC 1755051. PMID 15194568.

doi.org

Richy, F; Bruyere, O; Ethgen, O; Rabenda, V; Bouvenot, G; Audran, M; Herrero-Beaumont, G; Moore, A; Eliakim, R; Haim, M; Reginster, JY (2004). "Time dependent risk of gastrointestinal complications induced by nonsteroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach". Annals of the Rheumatic Diseases. 63 (7): 759–66. DOI:10.1136/ard.2003.015925. PMC 1755051. PMID 15194568.
Zell JA, Chang JC (november 2005). "Neoplastic fever: a neglected paraneoplastic syndrome". Support Care Cancer. 13 (11): 870–7. DOI:10.1007/s00520-005-0825-4. PMID 15864658.
Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Jüni P (2011). "Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis". BMJ. 342: c7086. DOI:10.1136/bmj.c7086. PMC 3019238. PMID 21224324. c7086.
Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C (august 2013). "Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials". Lancet. 382 (9894): 769–79. DOI:10.1016/S0140-6736(13)60900-9. PMC 3778977. PMID 23726390.
Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P (2011). "Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans". Proc. Natl. Acad. Sci. U.S.A. 108 (22): 9262–7. DOI:10.1073/pnas.1104836108. PMC 3107316. PMID 21518864.
Duggan KC, Walters MJ, Musee J, Harp JM, Kiefer JR, Oates JA, Marnett LJ (november 2010). "Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen". J. Biol. Chem. 285 (45): 34950–9. DOI:10.1074/jbc.M110.162982. PMC 2966109. PMID 20810665.
Hinz B, Cheremina O, Besz D, Zlotnick S, Brune K (2008). "Impact of naproxen sodium at over-the-counter doses on cyclooxygenase isoforms in human volunteers". Int J Clin Pharmacol Ther. 46 (4): 180–6. DOI:10.5414/CPP46180. PMID 18397691.
Van Hecken A, Schwartz JI, Depré M, De Lepeleire I, Dallob A, Tanaka W, Wynants K, Buntinx A, Arnout J, Wong PH, Ebel DL, Gertz BJ, De Schepper PJ (2000). "Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers". J Clin Pharmacol. 40 (10): 1109–20. DOI:10.1177/009127000004001005. PMID 11028250.
Gross GJ, Moore J (2004). "Effect of COX-1/COX-2 inhibition versus selective COX-2 inhibition on coronary vasodilator responses to arachidonic acid and acetylcholine". Pharmacology. 71 (3): 135–42. DOI:10.1159/000077447. PMID 15161995.
Hawkey CJ (2001). "COX-1 and COX-2 inhibitors". Best Pract Res Clin Gastroenterol. 15 (5): 801–20. DOI:10.1053/bega.2001.0236. PMID 11566042.
Harrington PJ, Lodewijk E (1997). "Twenty Years of Naproxen Technology". Org. Process Res. Dev. 1 (1): 72–76. DOI:10.1021/op960009e.

nih.gov

pubmed.ncbi.nlm.nih.gov

Richy, F; Bruyere, O; Ethgen, O; Rabenda, V; Bouvenot, G; Audran, M; Herrero-Beaumont, G; Moore, A; Eliakim, R; Haim, M; Reginster, JY (2004). "Time dependent risk of gastrointestinal complications induced by nonsteroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach". Annals of the Rheumatic Diseases. 63 (7): 759–66. DOI:10.1136/ard.2003.015925. PMC 1755051. PMID 15194568.
French L (2005). "Dysmenorrhea" (PDF). Am Fam Physician. 71 (2): 285–91. PMID 15686299.
Zell JA, Chang JC (november 2005). "Neoplastic fever: a neglected paraneoplastic syndrome". Support Care Cancer. 13 (11): 870–7. DOI:10.1007/s00520-005-0825-4. PMID 15864658.
Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Jüni P (2011). "Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis". BMJ. 342: c7086. DOI:10.1136/bmj.c7086. PMC 3019238. PMID 21224324. c7086.
Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C (august 2013). "Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials". Lancet. 382 (9894): 769–79. DOI:10.1016/S0140-6736(13)60900-9. PMC 3778977. PMID 23726390.
Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P (2011). "Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans". Proc. Natl. Acad. Sci. U.S.A. 108 (22): 9262–7. DOI:10.1073/pnas.1104836108. PMC 3107316. PMID 21518864.
Duggan KC, Walters MJ, Musee J, Harp JM, Kiefer JR, Oates JA, Marnett LJ (november 2010). "Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen". J. Biol. Chem. 285 (45): 34950–9. DOI:10.1074/jbc.M110.162982. PMC 2966109. PMID 20810665.
Hinz B, Cheremina O, Besz D, Zlotnick S, Brune K (2008). "Impact of naproxen sodium at over-the-counter doses on cyclooxygenase isoforms in human volunteers". Int J Clin Pharmacol Ther. 46 (4): 180–6. DOI:10.5414/CPP46180. PMID 18397691.
Van Hecken A, Schwartz JI, Depré M, De Lepeleire I, Dallob A, Tanaka W, Wynants K, Buntinx A, Arnout J, Wong PH, Ebel DL, Gertz BJ, De Schepper PJ (2000). "Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers". J Clin Pharmacol. 40 (10): 1109–20. DOI:10.1177/009127000004001005. PMID 11028250.
Gross GJ, Moore J (2004). "Effect of COX-1/COX-2 inhibition versus selective COX-2 inhibition on coronary vasodilator responses to arachidonic acid and acetylcholine". Pharmacology. 71 (3): 135–42. DOI:10.1159/000077447. PMID 15161995.
Hawkey CJ (2001). "COX-1 and COX-2 inhibitors". Best Pract Res Clin Gastroenterol. 15 (5): 801–20. DOI:10.1053/bega.2001.0236. PMID 11566042.
el Mouelhi M, Ruelius HW, Fenselau C, Dulik DM (1987). "Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen, and benoxaprofen". Drug Metab. Dispos. 15 (6): 767–72. PMID 2893700.

ncbi.nlm.nih.gov

Richy, F; Bruyere, O; Ethgen, O; Rabenda, V; Bouvenot, G; Audran, M; Herrero-Beaumont, G; Moore, A; Eliakim, R; Haim, M; Reginster, JY (2004). "Time dependent risk of gastrointestinal complications induced by nonsteroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach". Annals of the Rheumatic Diseases. 63 (7): 759–66. DOI:10.1136/ard.2003.015925. PMC 1755051. PMID 15194568.
Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Jüni P (2011). "Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis". BMJ. 342: c7086. DOI:10.1136/bmj.c7086. PMC 3019238. PMID 21224324. c7086.
Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C (august 2013). "Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials". Lancet. 382 (9894): 769–79. DOI:10.1016/S0140-6736(13)60900-9. PMC 3778977. PMID 23726390.
Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P (2011). "Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans". Proc. Natl. Acad. Sci. U.S.A. 108 (22): 9262–7. DOI:10.1073/pnas.1104836108. PMC 3107316. PMID 21518864.
Duggan KC, Walters MJ, Musee J, Harp JM, Kiefer JR, Oates JA, Marnett LJ (november 2010). "Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen". J. Biol. Chem. 285 (45): 34950–9. DOI:10.1074/jbc.M110.162982. PMC 2966109. PMID 20810665.

vimovo.com

"Vimovo's hotsite". vimovo.com. 11.03.2015.

web.archive.org

Naproxen.